DE69812601D1 - Titrierverfahren für komplexe viruszusammensetzung - Google Patents

Titrierverfahren für komplexe viruszusammensetzung

Info

Publication number
DE69812601D1
DE69812601D1 DE69812601T DE69812601T DE69812601D1 DE 69812601 D1 DE69812601 D1 DE 69812601D1 DE 69812601 T DE69812601 T DE 69812601T DE 69812601 T DE69812601 T DE 69812601T DE 69812601 D1 DE69812601 D1 DE 69812601D1
Authority
DE
Germany
Prior art keywords
viruses
species
type
virus composition
titration procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69812601T
Other languages
English (en)
Other versions
DE69812601T2 (de
Inventor
Catherine Gerdil
Jean-Francois Saluzzo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur SA filed Critical Aventis Pasteur SA
Application granted granted Critical
Publication of DE69812601D1 publication Critical patent/DE69812601D1/de
Publication of DE69812601T2 publication Critical patent/DE69812601T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/06—Quantitative determination
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE69812601T 1997-04-04 1998-04-03 Titrierverfahren für komplexe viruszusammensetzung Expired - Lifetime DE69812601T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9704371A FR2761698B1 (fr) 1997-04-04 1997-04-04 Methode de titrage d'une composition virale complexe
PCT/FR1998/000678 WO1998045709A1 (fr) 1997-04-04 1998-04-03 Methode de titrage d'une composition virale complexe

Publications (2)

Publication Number Publication Date
DE69812601D1 true DE69812601D1 (de) 2003-04-30
DE69812601T2 DE69812601T2 (de) 2003-10-09

Family

ID=9505710

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69812601T Expired - Lifetime DE69812601T2 (de) 1997-04-04 1998-04-03 Titrierverfahren für komplexe viruszusammensetzung

Country Status (15)

Country Link
US (1) US6890711B1 (de)
EP (1) EP0974055B1 (de)
KR (1) KR100543344B1 (de)
CN (1) CN1130465C (de)
AT (1) ATE235685T1 (de)
AU (1) AU737465B2 (de)
BR (1) BR9808482A (de)
CA (1) CA2285647C (de)
DE (1) DE69812601T2 (de)
DK (1) DK0974055T3 (de)
ES (1) ES2191299T3 (de)
FR (1) FR2761698B1 (de)
NZ (1) NZ500005A (de)
PT (1) PT974055E (de)
WO (1) WO1998045709A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1159969A1 (de) * 2000-05-30 2001-12-05 Aventis Pasteur Impfstoffzusammensetzung
US8589667B2 (en) 2010-04-19 2013-11-19 Apple Inc. Booting and configuring a subsystem securely from non-local storage

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2511702B1 (fr) * 1981-08-24 1985-09-13 Pasteur Institut Anticorps monoclonaux antipoliovirus pour l'identification du type et la differenciation intratypique de souches isolees de poliovirus, hybrides cellulaires pour leur fabrication et procede de diagnostic in vitro mettant en jeu des anticorps
GB8703696D0 (en) * 1987-02-18 1987-03-25 Oxford J S Influenza vaccine
FR2694022B1 (fr) * 1992-07-21 1994-09-30 Int Mycoplasma Procédé d'amplification des agents infectieux en diagnostic "in vitro" sur cultures cellulaires.
JPH06222062A (ja) * 1993-01-22 1994-08-12 Teijin Ltd ウイルス感染価および中和抗体価の測定法

Also Published As

Publication number Publication date
KR100543344B1 (ko) 2006-01-20
FR2761698B1 (fr) 1999-05-07
CA2285647A1 (fr) 1998-10-15
WO1998045709A1 (fr) 1998-10-15
DE69812601T2 (de) 2003-10-09
EP0974055A1 (de) 2000-01-26
DK0974055T3 (da) 2003-07-21
PT974055E (pt) 2003-08-29
FR2761698A1 (fr) 1998-10-09
CA2285647C (fr) 2008-11-18
AU737465B2 (en) 2001-08-23
CN1130465C (zh) 2003-12-10
EP0974055B1 (de) 2003-03-26
KR20010006045A (ko) 2001-01-15
ES2191299T3 (es) 2003-09-01
BR9808482A (pt) 2001-07-31
AU7055298A (en) 1998-10-30
US6890711B1 (en) 2005-05-10
ATE235685T1 (de) 2003-04-15
CN1259207A (zh) 2000-07-05
NZ500005A (en) 2001-07-27

Similar Documents

Publication Publication Date Title
DK0933082T3 (da) Fremgangsmåde til manipulation af celledifferentiering
DK1064303T3 (da) Monoklonale antistoffer, der er specifikke for det prostataspecifikke membranantigens ekstracellulære domæne
CY1111098T1 (el) Bodipy διαιθυλοακεταλη αμινοακεταλδεϋδης
DE69737126D1 (de) Hbv mutanten und methoden für deren nachweis
ATE221657T1 (de) Entstörung durch rheumafaktoren
NO20006109L (no) Analytisk metode som benytter multippel virusmerking
EP0902286A3 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
DK26587A (da) Monoklonalt antistof, maalemetode for glucosyleret protein ved anvendelse af det monoklonale antistofog kit omfattende dette
DE69812601T2 (de) Titrierverfahren für komplexe viruszusammensetzung
TR199801027T2 (xx) Epitelyom te�his ve tedavisi i�in y�ntem.
DK0740789T3 (da) Fremgangsmåde til at teste for mastitis i pattedyr samt system til udøvelse af fremgangsmåden
DE69033352T2 (de) Competitives enzym-testverfahren zum nachweis von phosphothioaten
IS5620A (is) Greiningar aðferðir
CA2419046A1 (en) Method for detecting or measuring hbv
ES522186A0 (es) Metodo de ensayo de anticuerpos.
DE3679926D1 (de) Nachweis von human-t-zellen-leukemievirus des typs-iii.
DE3851221T2 (de) Nichttrennender festphasen-enzymtest.
ES2132115T3 (es) Anticuerpos monoclonales contra el virus de la hepatitis c y su procedimiento de utilizacion.
TR199902757T2 (xx) Grup O HIV-1 vir�slerine ba�l� enfeksiyonlar�n tespiti i�in biyolojik testlerde kullan�labilen sentetik peptitler.
ATE41242T1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
ATE307201T1 (de) Srcr domäne-enthaltendes protein
DK0786089T3 (da) Fremgangsmåde til vurdering af afsætning af Bacillus thuringiensis-delta-endotoxin
FI843562L (fi) Foerfarande foer immunokemisk bestaemning av hepatitis b kaernantigener.
DK61798A (da) Kolorimetrisk fremgangsmåde til i laboratorieskala at bestemme effekten af cellulolytiske enzymer ved fuldskala-anvandelse
BR1100559B1 (pt) mÉtodo de sondagem para identificar anticorpos especÍficos para antÍgenos selecionados.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC